We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
PURITAN MEDICAL

Download Mobile App




Orthofix Acquires Blackstone for $333 Million

By HospiMedica staff writers
Posted on 28 Aug 2006
Orthofix International (Curaçao, Netherlands Antilles), a global diversified orthopedic products company, has agreed to buy Blackstone Medical (Springfield, MA, USA), a company dedicated to advancing techniques and technologies for the treatment of the human spine, for U.S.$333 million.

Blackstone distributes the Trinity multipotential cellular bone matrix, manufactured by Osiris Therapeutics (Baltimore, MD, USA), the only commercially produced adult stem cell biologic product for bone growth in the spine. More...
Blackstone has launched 14 new products in the last two years, including the Icon modular spinal fixation system, an advanced modular pedicle screw that offers greater latitude for surgeons performing minimally invasive surgery. Another product, the new Advent artificial cervical disc, which closely mimics the natural range of human motion, is slated for European Union (EU) release in the first quarter of 2007.

"This acquisition is a transformational event for Orthofix and a major step in our strategy, as it establishes a solid platform for accelerated sales and earnings expansion in the fastest-growing segment of the orthopedics industry,” said Orthofix CEO, Alan Milinazzo. "Our robust distribution channels give us the opportunity to significantly expand the availability of Blackstone's unique product portfolio around the world.”

The acquisition allows Orthofix to leverage Blackstone's engineering and market strength in the fusion, motion preservation, and biologic categories.



Related Links:
Orthofix International
Blackstone Medical

Gold Member
SARS‑CoV‑2/Flu A/Flu B/RSV Sample-To-Answer Test
SARS‑CoV‑2/Flu A/Flu B/RSV Cartridge (CE-IVD)
Antipsychotic TDM Assays
Saladax Antipsychotic Assays
LED Surgical Lamp
ACEMST35/57
ow Frequency Pulse Massager
ET10 L
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to HospiMedica.com and get access to news and events that shape the world of Hospital Medicine.
  • Free digital version edition of HospiMedica International sent by email on regular basis
  • Free print version of HospiMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of HospiMedica International in digital format
  • Free HospiMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Patient Care

view channel
Image: The revolutionary automatic IV-Line flushing device set for launch in the EU and US in 2026 (Photo courtesy of Droplet IV)

Revolutionary Automatic IV-Line Flushing Device to Enhance Infusion Care

More than 80% of in-hospital patients receive intravenous (IV) therapy. Every dose of IV medicine delivered in a small volume (<250 mL) infusion bag should be followed by subsequent flushing to ensure... Read more
Copyright © 2000-2025 Globetech Media. All rights reserved.